Skip to main content
. 2020 Mar 7;2020:7146028. doi: 10.1155/2020/7146028

Table 2.

Patient characteristics.

Variables Normal group (N = 250) SVD group (N = 188) DVD group (N = 184) MVD group (N = 266)
Male (n (%)) 110 (44.0%) 99 (52.7%) 118 (64.1%)∗∗∗† 192 (72.2%)∗∗∗†††
Age (years) 60.86 ± 9.69 64.15±11.32∗∗ 65.77±10.55∗∗∗ 68.18±10.76∗∗∗†††
BMI (kg/m2) 24.95 ± 3.45 24.23 ± 3.03 24.49 ± 2.95 24.64 ± 4.67
Smoking (n (%)) 67 (36.6%) 75 (39.9%)∗∗ 89 (48.4%)∗∗∗ 102 (38.3%)∗∗
Hypertension (n (%)) 153 (61.2%) 126 (67.0%) 138 (75.0%)∗∗ 187 (70.8%)
Hyperlipidaemia (n (%)) 35 (14.0%) 29 (15.4%) 26 (14.1%) 24 (9.1%)
Diabetes (n (%)) 55 (22.0%) 78 (41.5%)∗∗∗ 68 (37.0%)∗∗ 113 (42.5%)∗∗∗
TC (mmol/L) 4.36 ± 0.95 4.36 ± 1.15 4.34 ± 1.10 4.48 ± 1.07
LDL-C (mmol/L) 2.57 ± 0.80 2.63 ± 0.99 2.64 ± 0.94 2.76 ± 0.90
HDL-C (mmol/L) 1.22 ± 0.32 1.15 ± 0.37 1.10±0.29∗∗∗ 1.08±0.29∗∗∗†
Non-HDL-C (mmol/L) 3.15 ± 0.89 3.21 ± 1.11 3.23 ± 1.09 3.40±1.02∗∗
Non-HDL/HDL 2.76 ± 1.04 3.04 ± 1.28 3.15±1.37∗∗ 3.33±1.27∗∗∗†
hsCRP (mg/L) 2.48 ± 4.51 12.07±23.44∗∗∗ 12.03±18.20∗∗∗ 17.31±30.09∗∗∗†
TnI (μg/L) 0.02 ± 0.06 9.50±24.40∗∗∗ 8.55±24.21∗∗∗ 12.59±28.27∗∗∗
CK-MB (U/L) 1.35 ± 1.02 36.04±82.36∗∗∗ 33.14±82.14∗∗∗ 32.59±75.07∗∗∗
Pro-BNP (fmol/mL) 249.31 ± 959.85 1370.66±2787.54∗∗∗ 1096.83±1552.57∗∗∗ 2341.45±4984.23∗∗∗†
Users of statins (%) 67 (26.8%) 87 (46.3%)∗∗∗ 91 (49.5%)∗∗∗ 130 (48.9%)∗∗∗

SVD: single-vessel disease; DVD: double-vessel disease; MVD: multivessel disease; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; non-HDL-C: non-high-density lipoprotein cholesterol; non-HDL/HDL: non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio; hsCRP: high-sensitivity C-reactive protein; TnI: troponin I; CK-MB: creatine kinase isoenzyme; pro-BNP: brain natriuretic peptide. Compared with the normal group: P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001. Compared with the SVD group: P < 0.05, ††P < 0.01, and †††P < 0.001.